Robbins And Cotran Pathologic Basis Of Disease

2,895.00

In stock


Compare
  Ask a Question   Chat Now
Categories: ,

Provides uniquely authoritative and readable coverage, ideal for usage or specialty Board preparation, as well as for course work. Covers the hot topics you need to know about, including novel therapies for hepatitis C, classification of lymphomas, unfolded protein response, non-apoptotic pathways of cell death, coronavirus infections, liquid biopsy for cancer detection, regulation of iron Absorption, clonal hematopoiesis and atherosclerosis, thrombotic microangiopathies, heparin-induced thrombocytopenias, inflammatory myopathies, genetic tools for treatment of cystic fibrosis, and many more. Uses an outstanding full-color, user-friendly design to simplify your study and quickly direct you to the information you need to know, with learning features such as boldface overviews at the beginning of each section, key concepts boxes, suggested readings, schematic diagrams that illustrate complex concepts, and new gross and microscopic figures for clarity of morphology. Brings you up to date with the latest information in molecular and genetic testing, mechanisms of disease, personalized medicine and its impact on treatment of human diseases, The role of microbiome and metabolome in noncommunicable diseases, and much more. New to the edition from South Asia – neoplasia infectious diseases diseases of white blood cells, lymph nodes, spleen, and thymus red blood cell and bleeding disorders the lung head and neck the gastrointestinal tract liver and gallbladder the kidney the breast the endocrine system The skin the central nervous system The eye transfusion medicine.

0 out of 5
books.dailylawtimes@gmail.com
7737033336

General Inquiries

There are no inquiries yet.

Main Menu

Robbins And Cotran Pathologic Basis Of Disease

2,895.00

Add to Cart
Chat Now
Chat Now
Questions, doubts, issues? We're here to help you!
Connecting...
None of our operators are available at the moment. Please, try again later.
Our operators are busy. Please try again later
:
:
:
Have you got question? Write to us!
:
:
This chat session has ended
Was this conversation useful? Vote this chat session.
Good Bad